Picture of Hisamitsu Pharmaceutical Co logo

4530 — Hisamitsu Pharmaceutical Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Table: Hisamitsu -Q1 group results

Jul 10 (Reuters)- 
             Hisamitsu Pharmaceutical Co Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  May 31, 2019        May 31, 2018     Feb 29, 2020 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               29.23               33.51           143.50    
                   (-12.8 pct)         (-7.2 pct)       (+0.1 pct)  
  Operating            2.78                4.36            22.90    
                   (-36.3 pct)         (-14.4 pct)      (+2.8 pct)  
  Recurring            2.86                4.45            25.50    
                   (-35.6 pct)         (-10.0 pct)      (+3.5 pct)  
  Net                  1.91                3.45            19.40    
                   (-44.6 pct)         (-6.0 pct)       (+1.0 pct)  
  EPS               23.15 yen           41.27 yen       234.69 yen  
  EPS Diluted       23.13 yen           41.23 yen                   
  Ann Div                               82.50 yen        83.00 yen  
  -Q2 div                               41.25 yen        41.50 yen  
  -Q4 div                               41.25 yen        41.50 yen  
  
  NOTE - Hisamitsu Pharmaceutical Co Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T

Recent news on Hisamitsu Pharmaceutical Co

See all news